UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003626
Receipt number R000004398
Scientific Title Study investigating the prevalence of primary insomnia responsive to proton pump inhibitor treatment
Date of disclosure of the study information 2010/05/24
Last modified on 2010/05/17 16:58:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study investigating the prevalence of primary insomnia responsive to proton pump inhibitor treatment

Acronym

proton pump inhibitor treatment for primary insomnia

Scientific Title

Study investigating the prevalence of primary insomnia responsive to proton pump inhibitor treatment

Scientific Title:Acronym

proton pump inhibitor treatment for primary insomnia

Region

Japan


Condition

Condition

primary insomnia

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Clarify the number of cases with insomnia who are responsive to PPI treatment

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Canges of QOLRAD-J, ESS, PSQI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of 20mg/day omeprazole

Interventions/Control_2

placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who need administration of a sleeping medicine for the treatment of insomnia.

Key exclusion criteria

Usage of a sleeping medicine in 2 weeks.
Cases treated as mental illness.
Usage of PPI or H2RA in 2 weeks.
With diseases that may influence sleep.
Pregnant or lactating women.
With allergy to omeprazole etc.
Others which attending doctors decide not suitable.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshikazu Kinoshita

Organization

Shimane University

Division name

School of Medicine

Zip code


Address

89-1, Enya-cho, Izumo

TEL

0853-20-2190

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Shimane University

Division name

executive department

Zip code


Address


TEL


Homepage URL


Email

ishikazu@jn.shimane-u.ac.jp


Sponsor or person

Institute

Department of Gastroenterology and Hepatology, Shimane University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterology and Hepatology, Shimane University School of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 05 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2010 Year 04 Month 26 Day

Date of IRB


Anticipated trial start date

2010 Year 05 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry

2012 Year 12 Month 01 Day

Date trial data considered complete

2012 Year 12 Month 01 Day

Date analysis concluded

2012 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 05 Month 17 Day

Last modified on

2010 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004398